Trials / Completed
CompletedNCT02805881
Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Neurolief Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neurolief system | Non-invasive cephalic neurostimulation device |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2016-06-20
- Last updated
- 2021-09-05
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02805881. Inclusion in this directory is not an endorsement.